CSEM
Swiss public-private R&D center developing and transferring world-class technologies in precision manufacturing (including additive manufacturing), digital technologies, and sustainable energy for industrial partners.
- CEO / Founder
- Alexandre Pauchard
- Team Size
- 501-1000
- Stage
- Active
- Total Funding
- $115.4M
- Latest Round
- Grant
- Key Investors
- Canton of Neuchâtel; Swiss Federal Council; Canton of Bern; Swiss Confederation; BKW Inc.
Technology & Products
Key Products
CSEM's portfolio includes solutions in data & AI (software/hardware for data collection, processing, secure transmission), lab automation, micro-nano optics, scientific instruments, and custom ASIC/IP solutions for medical, industrial, and mobility applications. They also focus on IoT, wearables, edge computing, and ultra-low power microtechnology.
Technological Advantage
40+ years of precision manufacturing expertise; 180 patent families; ISO-certified processes; unique cross-disciplinary capability spanning AM, MEMS, photonics, AI, and energy in one center; strong academic ties to EPFL and ETH Zurich.
Differentiation
Value Proposition
Enables Swiss and global industrial companies to innovate by providing access to world-class R&D expertise across AM, photonics, MEMS, digital health, and sustainable energy — transferring technologies from lab to marketable products while sharing IP risk.
How They Differentiate
One of the few RTOs combining precision manufacturing, AM, photonics, AI and sustainable energy in a single center; deep Swiss industry embeddedness (Swatch Group, Rolex, Richemont as board shareholders); strong track record of 50+ spin-offs; ISO-certified production capabilities enabling direct technology transfer to manufacturing. CSEM also differentiates by acting as a "transmission belt" between academia and industry, providing access to world-class R&D expertise and sharing IP risk.
Market & Competition
Target Customers
Swiss and international industrial companies in aerospace, watchmaking, medical devices, automotive, electronics, and energy sectors seeking R&D partnership and technology transfer.
Industry Verticals
Aerospace; Medical Devices; Watchmaking; Automotive; Electronics; Energy; Life Sciences; Railway
Competitors
Alpex Pharma, EUSA Pharma, Banyan Biomarkers (as identified by CB Insights for similar products/services)
Growth & Milestones
Growth Metrics
650+ employees across 7 Swiss sites; 230+ industrial clients per year; 180 patent families; 50+ spin-offs and start-ups created since 1984; over 45% of annual revenue from industrial cooperation
Major Milestones
1984: Founded as Swiss public-private R&D center; 2009: Cuffless blood pressure monitoring technology developed (commercialized via Aktiia); 2016: Unveiled C-CAT continuous printing technology at Euromold (via partner CARIMA); 2024: MgC bilayer approach for anode-free solid-state batteries; 2025: 7 sites across Switzerland, 650+ employees, 230 industrial clients/year; 2026: Corner Cube Mechanism for ESA weather forecasting satellite
Notable Customers
While specific customer names are not publicly disclosed, CSEM's board shareholders include Swatch Group, Rolex, and Richemont, indicating strong ties to the Swiss watchmaking industry. They also partner with various industrial companies across different sectors.